Effects of N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of neutral- and acid α-glucosidases in human fibroblasts and HepG2 cells

This publication has 27 references indexed in Scilit:

• Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors.
  Gut, 1986
• Smoothing Effect of a New α-Glucosidase Inhibitor BAY m 1099 on Blood Glucose Profiles of Sulfonylurea-Treated Type II Diabetic Patients
  Hormone and Metabolic Research, 1986
• Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat α1-proteinase inhibitor and α1-acid glycoprotein
  Biochemical Journal, 1986
• Inhibitors of oligosaccharide processing
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1985
• Effect of 1-Desoxynojirimycin Derivatives on Small Intestinal Disaccharidase Activities and on Active Transport in vitro
  Digestion, 1985
• Cell Type Dependent Inhibition of Transport of Cathepsin D in HepG2 Cells and Fibroblasts Exposed to Deoxy-manno-nojirimycin and Deoxynojirimycin
  Biological Chemistry Hoppe-Seyler, 1985
• Lysosomal glycogen storage mimicking the cytological picture of Pompe’s disease as induced in rats by injection of an α-glucosidase inhibitor
  Virchows Archiv B Cell Pathology Including Molecular Pathology, 1982
• Nojirimycin-A potent inhibitor of purified lysosomal alpha-glucosidase from human liver
  Biochemical and Biophysical Research Communications, 1982
• Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface Antigen
  Science, 1980
• Effect of the?? glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics
  Diabetologia, 1979